B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by MAP2K mutants

REACTOME PATHWAY
Reactome: R-HSA-96521694 genes26 compounds

The Signaling by MAP2K mutants pathway (Reactome ID: R-HSA-9652169) involves 4 genes and is affected by 26 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

MAP2K1MAP2K2MAPK1MAPK3

Compounds Affecting Signaling by MAP2K mutants

#CompoundTargets HitStudies
1pd980597
2trametinib296
3Sorafenib300
4plumbagin [Supplementary Concept]300
5alsterpaullone12
6kenpaullone8
7isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
8withaferin300
9Dasatinib299
10Axitinib298
11Vemurafenib298
12tyrphostin ag 14784
13Clotrimazole296
14sp600125117
15fisetin78
16Progesterone299
172-Chloroadenosine 2-Chloroadenosine.300
18Benzalkonium Compounds299
19Calcimycin216
20daph2
21Diphenhydramine14
22ha10044
23Lithocholic Acid300
24Loratadine296
25trequinsin hydrochloride1
26arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside) [Supplementary Concept] isolated from300

About the Signaling by MAP2K mutants Pathway

The Signaling by MAP2K mutants pathway is catalogued in Reactome (ID: R-HSA-9652169) and involves 4 genes. In the BiohacksAI corpus, 26 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include MAP2K1, MAP2K2, MAPK1, MAPK3.